COMMUNIQUÉS West-GlobeNewswire

-
Firefly Neuroscience to be Added to the Russell Microcap® Index
23/06/2025 -
Candel Therapeutics Appoints Charles Schoch as Chief Financial Officer
23/06/2025 -
Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply
23/06/2025 -
BioStem Technologies Completes Enrollment in Clinical Trial Evaluating BioREtain® Amnion Chorion for Treatment of Diabetic Foot Ulcers
23/06/2025 -
Transactions in Connection with Share Buy-back Program
23/06/2025 -
NetraMark's AI Significantly Outperforms ChatGPT, DeepSeek and Traditional Machine Learning in Clinical Trial Subpopulation Discovery, Offers New Path for Trial Success
23/06/2025 -
NeuroOne® Patient Surpasses One Year Milestone of Seizure Freedom Following Treatment with OneRF® Ablation System
23/06/2025 -
Eyenovia Announces Closing of $50 Million Private Placement, Successful Accumulation of More Than One Million HYPE Tokens, and Update on its Optejet Development Program
23/06/2025 -
Sienna Senior Living Expands in the Greater Toronto Area
23/06/2025 -
Biodexa Unveils "Serenta" as the Name of its Upcoming Phase 3 Study In Familial Adenomatous Polyposis (FAP)
23/06/2025 -
IMBRUVICA® (ibrutinib) reçoit un avis favorable du CHMP pour le traitement des patients atteints d’un lymphome à cellules du manteau (LCM) non préalablement traités et éligibles à une autogreffe de cellules souches
23/06/2025 -
Cepham Calls on Natural Products Industry to Lead a Precision Wellness Revolution for Men
23/06/2025 -
Michael Mahler, PhD Joins Exagen as Chief Scientific Officer to Enhance Leadership in Autoimmune Diagnostics
23/06/2025 -
Healthcare Financial Management Association recognizes Dan Liljenquist for contributions to healthcare
23/06/2025 -
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer with KRAS G12 Mutations
23/06/2025 -
HFMA Announces Kiran Batheja as National Chair
23/06/2025 -
PracticeLink Announces Strategic Leadership Realignment to Advance Service to Physicians and Recruiters
23/06/2025 -
Major shareholder announcement
23/06/2025 -
Sharecare wins 21 Digital Health Awards in Spring 2025 competition
23/06/2025
Pages